These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 15823554

  • 1. Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1).
    Kwak HB, Jin HM, Ha H, Kang MJ, Lee SB, Kim HH, Lee ZH.
    Biochem Biophys Res Commun; 2005 May 20; 330(4):1080-6. PubMed ID: 15823554
    [Abstract] [Full Text] [Related]

  • 2. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 20; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 3. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J.
    J Bone Miner Res; 2003 Dec 20; 18(12):2159-68. PubMed ID: 14672351
    [Abstract] [Full Text] [Related]

  • 4. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov 01; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
    Woo JT, Nakagawa H, Krecic AM, Nagai K, Hamilton AD, Sebti SM, Stern PH.
    Biochem Pharmacol; 2005 Jan 01; 69(1):87-95. PubMed ID: 15588717
    [Abstract] [Full Text] [Related]

  • 11. TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis.
    Kanazawa K, Azuma Y, Nakano H, Kudo A.
    J Bone Miner Res; 2003 Mar 01; 18(3):443-50. PubMed ID: 12619928
    [Abstract] [Full Text] [Related]

  • 12. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.
    Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, Inoue J.
    EMBO J; 2001 Mar 15; 20(6):1271-80. PubMed ID: 11250893
    [Abstract] [Full Text] [Related]

  • 13. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA.
    Bone; 2006 May 15; 38(5):678-85. PubMed ID: 16309985
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
    Mbalaviele G, Anderson G, Jones A, De Ciechi P, Settle S, Mnich S, Thiede M, Abu-Amer Y, Portanova J, Monahan J.
    J Pharmacol Exp Ther; 2006 Jun 15; 317(3):1044-53. PubMed ID: 16501068
    [Abstract] [Full Text] [Related]

  • 15. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
    Nishida S, Tsubaki M, Hoshino M, Namimatsu A, Uji H, Yoshioka S, Tanimori Y, Yanae M, Iwaki M, Irimajiri K.
    Biochem Biophys Res Commun; 2005 Mar 04; 328(1):91-7. PubMed ID: 15670755
    [Abstract] [Full Text] [Related]

  • 16. TNF-alpha expression is transcriptionally regulated by RANK ligand.
    Zou W, Amcheslavsky A, Takeshita S, Drissi H, Bar-Shavit Z.
    J Cell Physiol; 2005 Feb 04; 202(2):371-8. PubMed ID: 15389596
    [Abstract] [Full Text] [Related]

  • 17. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
    Kim CH, Moon SK.
    Arch Biochem Biophys; 2005 Mar 15; 435(2):264-72. PubMed ID: 15708369
    [Abstract] [Full Text] [Related]

  • 18. Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase.
    Lee SJ, Kim HM, Cho YH, Park K, Kim EJ, Jung KH, Kim CH, Kim WJ, Moon SK.
    Oncol Rep; 2007 Sep 15; 18(3):729-36. PubMed ID: 17671727
    [Abstract] [Full Text] [Related]

  • 19. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha.
    Furusu A, Nakayama K, Xu Q, Konta T, Kitamura M.
    J Cell Physiol; 2007 Mar 15; 210(3):703-10. PubMed ID: 17133355
    [Abstract] [Full Text] [Related]

  • 20. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells.
    Cohen M, Meisser A, Haenggeli L, Bischof P.
    Mol Hum Reprod; 2006 Apr 15; 12(4):225-32. PubMed ID: 16520344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.